Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors
Product description

Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for parathyroid hormone (PTH) and for parathyroid hormone-related protein (PTHrP). FORTEO (teriparatide) is recombinant human parathyroid hormone analog (1-34), marketed since 2002 for the treatment of osteoporosis and related indications where an increase of bone mass is desirable. With 2012 sales of over US$ 1 bln and the forthcoming patent expiry, teriparatide is an attractive target for biosimilar developments as well as for next generation improved PTH receptor agonist products.

The present Competitive Intelligence report about PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors provides a competitor evaluation in the field of protein- and peptide-based agonists  of the parathyroid hormone (PTH) receptor for the treatment of osteoporosis as of October 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of proteins and peptides as agonists of the parathyroid hormone (PTH) receptor. In addition, the report lists company-specific R&D pipelines of PTH receptor agonists.

Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors
Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors

Table of Contents

• 1st Generation PTH Receptor Agonists
• Teriparatide Biosimilars
• PTH-related Proteins/Peptides
• PTH Variants
• Nasal Drug Delivery Solutions for rhPTH Receptor Agonists
• Oral Drug Delivery Solutions for rhPTH Receptor Agonists
• Transdermal Drug Delivery Solutions for rhPTH Receptor Agonists
• Corporate PTH Receptor Agonist RandD Pipelines

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • January 2015
  • by Global Data

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018 Summary GlobalData estimates that the 2013 sales for the Cushing’s syndrome (CS) therapeutic market was approximately ...

Testosterone acetate Chemical Report

Testosterone acetate Chemical Report

  • $ 4 609
  • Industry report
  • April 2015
  • by PureData

Testosterone acetate Chemical Report This Testosterone acetate Chemical World Consumption Reportt provides data on the net consumption of Testosterone acetate in each of the countries listed. The substance ...

Orally Inhaled Corticosteroids to 2022

Orally Inhaled Corticosteroids to 2022

  • $ 2 850
  • Industry report
  • April 2015
  • by Greystone Research Associates

Asthma continues to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.